Oncologists Urge Faster Biomarker Results for Lung Cancer Patients

Diagnostic testing companies should do a better job of turning around biomarker test results for lung cancer patients, according to a survey reported at the American Society of Clinical Oncology (ASCO) annual meeting on June 4. Out of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker […]

READ MORE..


China Emerging as Vital Point of Care (POC) Market

  Reforms in China, along with increasing incidence of cancer, diabetes, heart disease and infectious diseases such as HIV, hepatitis and STDs, provide new opportunities for point-of-care, advanced tests and molecular diagnostics, reports medical market research publisher Kalorama Information.   China’s potential as a point of care (POC) market was already growing when the coronavirus […]

READ MORE..


AACC releases guidance on kidney injury lab testing

The American Association for Clinical Chemistry (AACC) released guidance on lab testing for acute kidney injury (AKI) patients that proposes new diagnostic thresholds for whether a patient has AKI with creatinine testing. One of the major recommendations is to propose that clinicians use the 20/20 AACC acute kidney injury criteria to determine whether a patient […]

READ MORE..


Infographic: Kalorama Information’s Guide to Diagnostic Biomarkers

This infographic is based on the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others) by leading medical market research publisher Kalorama Information. Purchase the report for more insights on the past, present, and future of this important market.  

READ MORE..


Remote Patient Monitoring and Telehealth: 5 Years of Growth Forecast for $54 Billion Market

  Before COVID-19, the telehealth industry was evolving slowly with slight gains annually.  Today, the pandemic has thrust the world into a new era of remote life, including managing, monitoring and treating patients and their health conditions at a pace never experienced before.  As a result of COVID-19, the global market for patient monitoring and […]

READ MORE..


3 Growth Trends in $472 Billion Global Medical Device Market

  COVID-19, mergers & acquisitions, and innovation spurred notable gains in the sale of medical devices in 2020   The global market for medical devices rose to $472 billion in 2020, increasing 5.1% for the year over 2019, according to new data published in The Global Market for Medical Devices, 11th Edition, the latest report […]

READ MORE..


At-Home Testing Expanding Reach Beyond COVID-19 Pandemic

Over the years, the increasing introduction of transportable, portable, and handheld medical instruments has resulted in the migration of point-of-care (POC) testing from the hospital environment to a range of medical and non-medical environments including the workplace, home, disaster care and most recently, convenience clinics. In the face of the ongoing global COVID-19 pandemic, the […]

READ MORE..


Point of Care Test Market is Ravaged, and Helped By Pandemic

Kalorama Information reported a mixed result with point of care testing, defined by tests that can deliver a result meaningful during a patient visit with a provider or on their own.  In 2020, sales of POC testing reached $29,316 million, according to Kalorama Information, a sister publication to Lab Pulse.  That’s up double digits from […]

READ MORE..


Watch the Companies That Make Cell and Gene Therapies For Pharma, Says New Report

There’s much talk about cell and gene therapy but a new report from a leading market research firm says that there’s a growing market over nearly two billion dollars for companies that make the cell and gene therapies. In 2020, the total global cell and gene therapy BCMO market reached $1,842 million. Over the following […]

READ MORE..


Global Biomarker Test Product Sales to Reach $63 Billion in 2027

Total global sales of biomarker test products are projected to reach nearly $63 billion in 2027 with the majority of sales coming from the United States, Western Europe, and Japan, according to new data by leading medical market research publisher Kalorama Information in the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, […]

READ MORE..